We are live on
!
Find out more
EPM
Equitec Proprietary Markets Portfolio holdings
AUM
$187M
1-Year Est. Return
179.87%
This Fund
S&P 500
This Quarter
Est. Return
+16.55%
1 Year Est. Return
+179.87%
3 Year Est. Return
+470.49%
5 Year Est. Return
+544.99%
10 Year Est. Return
–
AUM
$141M
AUM Growth
+$38.3M
(+37%)
Cap. Flow
+$26.8M
Cap. Flow
% of AUM
19.03%
Top 10 Holdings %
Top 10 Hldgs %
80.14%
Holding
80
New
21
Increased
12
Reduced
10
Closed
14
Top Buys
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.82M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$6.87M |
| 3 |
K
Kellanova
K
|
+$2.64M |
| 4 |
KBDC
Kayne Anderson BDC
KBDC
|
+$1.37M |
| 5 |
AMED
Amedisys
AMED
|
+$1.01M |
Top Sells
| 1 |
X
US Steel
X
|
+$1.74M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$1.09M |
| 3 |
SiriusXM
SIRI
|
+$396K |
| 4 |
DFS
Discover Financial Services
DFS
|
+$173K |
| 5 |
Cadiz
CDZI
|
+$152K |
Sector Composition
| 1 | Materials | 7.21% |
| 2 | Healthcare | 7.03% |
| 3 | Consumer Staples | 2.22% |
| 4 | Financials | 0.95% |
| 5 | Industrials | 0.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| $16.8M | 11.93% |
+30,000
| New | +$17.6M |
|
|
ITCI
2
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $15.2M | 10.81% |
+115,200
| New | +$14.4M |
|
|
PARA
3
PUT
DELISTED
Paramount Global Class B
PARA
| $15.1M | 10.75% |
1,263,600
+590,000
| +88% | +$6.6M |
|
|
X
4
PUT
DELISTED
US Steel
X
| $13.5M | 9.6% |
319,400
-547,900
| -63% | -$20.7M |
|
|
PARA
5
CALL
DELISTED
Paramount Global Class B
PARA
| $10.3M | 7.3% |
858,400
+242,700
| +39% | +$2.71M |
|
|
X
6
DELISTED
US Steel
X
| $10.1M | 7.21% |
239,800
-45,990
| -16% | -$1.74M |
|
|
K
7
CALL
DELISTED
Kellanova
K
| $9.54M | 6.78% |
115,600
+21,900
| +23% | +$1.8M |
|
|
8
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| $8.39M | 5.97% |
15,002
+15,000
| +750,000% | +$8.82M |
|
|
ITCI
9
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $7.27M | 5.17% |
+55,100
| New | +$6.87M |
|
|
X
10
CALL
DELISTED
US Steel
X
| $6.52M | 4.64% |
154,300
-367,800
| -70% | -$13.9M |
|
|
K
11
PUT
DELISTED
Kellanova
K
| $4.76M | 3.38% |
57,700
+50,900
| +749% | +$4.18M |
|
|
ITCI
12
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.8M | 2.7% |
+28,800
| New | +$3.59M |
|
|
13
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| $2.8M | 1.99% |
+5,000
| New | +$2.94M |
|
|
K
14
DELISTED
Kellanova
K
| $2.73M | 1.94% |
33,060
+32,200
| +3,744% | +$2.64M |
|
|
AMED
15
PUT
DELISTED
Amedisys
AMED
| $2.15M | 1.53% |
23,200
+17,200
| +287% | +$1.59M |
|
|
AMED
16
DELISTED
Amedisys
AMED
| $1.57M | 1.12% |
17,000
+11,000
| +183% | +$1.01M |
|
|
KBDC
17
Kayne Anderson BDC
KBDC
$910M
| $1.32M | 0.94% |
+81,332
| New | +$1.37M |
|
18
PUT
AllianceBernstein
AB
$3.54B
| $927K | 0.66% |
+24,200
| New | +$911K |
|
|
WBA
19
PUT
DELISTED
Walgreens Boots Alliance
WBA
| $922K | 0.66% |
+82,500
| New | +$896K |
|
|
BLUE
20
PUT
DELISTED
bluebird bio
BLUE
| $741K | 0.53% |
+151,800
| New | +$913K |
|
|
SPR
21
DELISTED
Spirit AeroSystems
SPR
| $610K | 0.43% |
17,700
+2,200
| +14% | +$75.2K |
|
|
WBA
22
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $560K | 0.4% |
+50,100
| New | +$544K |
|
|
JNPR
23
CALL
DELISTED
Juniper Networks
JNPR
| $543K | 0.39% |
+15,000
| New | +$549K |
|
|
BLUE
24
DELISTED
bluebird bio
BLUE
| $540K | 0.38% |
+110,714
| New | +$666K |
|
|
SPR
25
PUT
DELISTED
Spirit AeroSystems
SPR
| $517K | 0.37% |
15,000
+5,000
| +50% | +$171K |
|
Similar funds
PP
WWA
CQWA
CI
TH
BAH
BWG
AWS
Equitec Proprietary Markets's Q1 2025 Portfolio in Review
As of Q1 2025, Equitec Proprietary Markets held 80 positions worth $141M, up 37% from $102M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Equitec Proprietary Markets deployed $26.8M of net new capital in Q1 2025, opening 21 new positions and adding to 12 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 55,100 shares worth $7.27M.
By sector, the portfolio is most concentrated in Materials at 7.2% of assets, down from 9.5% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was US Steel, an estimated $1.74M trimmed.
- Equitec Proprietary Markets's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 55,100 shares worth $7.27M.
- Equitec Proprietary Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $8.82M increase.
- Equitec Proprietary Markets's biggest Q1 2025 reduction was US Steel, cutting an estimated $1.74M.
- Equitec Proprietary Markets fully exited Paramount Global Class B in Q1 2025, selling an estimated $1.09M.
- Equitec Proprietary Markets's ten largest holdings make up 80% of its $141M portfolio in Q1 2025.
- Equitec Proprietary Markets opened 21 new positions and closed 14 in Q1 2025.
- Equitec Proprietary Markets's portfolio value rose 37% quarter-over-quarter to $141M.
Based on Equitec Proprietary Markets's 13F filing for Q1 2025, filed 14 May 2025.